Total US medical devices industry M&A deals in Q4 2018 worth $4.35bn were announced, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 13.6% over the previous quarter and a drop of 3.7% when compared with the last four-quarter average of $4.62bn.

The United States held a 48.8% share of the global medical devices industry M&A deal value that totalled $8.91bn in Q4 2018.

In terms of deal activity, the United States recorded 42 deals during Q4 2018, marking a drop of 26.3% over the previous quarter and a drop of 19.2% over the last four-quarter average.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

US medical devices industry M&A deals in Q4 2018: Top deals

The top five medical devices industry M&A deals accounted for 93.4% of the overall value during Q4 2018.

The combined value of the top five medical devices industry M&A deals stood at $4.06bn, against the overall value of $4.35bn recorded for the quarter. The top announced medical devices industry M&A deal tracked by GlobalData in Q4 2018 was Colfax’s $3.15bn acquisition of DJO Global.

In second place was the $365m acquisition of Buffalo Filter by ConMed and in third place was Stryker‘s $220m acquisition of HyperBranch Medical Technology.

The $200m acquisition of Cianna Medical by Merit Medical Systems and NeoGenomics‘ acquisition of Genoptix for $125m held fourth and fifth positions, respectively.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.